Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.

NCT07583147 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07583147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07583147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
December 31, 2029
Enrollment
117 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage